Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period.
Glutamatergic signaling plays an important role in the behavioral and molecular plasticity observed in behavioral sensitization to cocaine. Redistribution of the glutamate receptors in the synaptosomal membrane fraction was investigated in the nucleus accumbens, dorsolateral striatum, and ventral tegmental area at 1 or 21 days of withdrawal in behaviorally sensitized rats. At 1 day of withdrawal, there were no changes in either tissue level or redistribution of glutamate receptors in nucleus accumbens core and shell and ventral tegmental area. At 21 days of withdrawal, there was a decrease in the expression of mGluR2/3 protein in core and shell, an increase in GluR1 and a decrease in Homer1b/c proteins in the nucleus accumbens core tissue. In dorsolateral striatum, the tissue level of NMDAR2B protein was increased. Moreover, there was an augmented presence of AMPA (GluR1, GluR2), NMDA (NMDAR1, 2A, 2B), and group 1 metabotropic glutamate receptor (mGluR5) proteins in the synaptosomal fraction in core and shell of the nucleus accumbens. There was also an increase in synaptosomal mGluR2/3 protein in nucleus accumbens core. The redistribution of glutamate receptors was selective for nucleus accumbens since no changes were observed in the dorsolateral striatum and ventral tegmental area. While the tissue level of the Homer1b/c protein was selectively reduced in nucleus accumbens core, that of PSD95, PICK1, and actin was not changed in any of the brain regions examined. However, the synaptosomal membrane fraction level of Homer1b/c and PSD95 was increased in nucleus accumbens core and shell, with no changes in PICK1, and a decrease in actin protein. These observations suggest that significant redistribution of glutamate receptors and postsynaptic scaffolding proteins into synaptosomal membrane fraction is associated with withdrawal from behavioral sensitization to cocaine.
Ghasemzadeh
M B
MB
Department of Biomedical Sciences, Integrative Neuroscience Research Center, Marquette University, Milwaukee, WI 53201, USA. behnam.ghasemzadeh@marquette.edu
Mueller
C
C
Vasudevan
P
P
D000199:Actins / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D003042:Cocaine / Q000008:administration & dosage*; D019970:Cocaine-Related Disorders / Q000378:metabolism* / Q000473:pathology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D000076122:Disks Large Homolog 4 Protein; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D005786:Gene Expression Regulation / Q000187:drug effects; D000072233:Homer Scaffolding Proteins; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D017470:Receptors, Glutamate / Q000145:classification / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism* / Q000473:pathology; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D017557:Ventral Tegmental Area / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure
D000199:Actins; D002352:Carrier Proteins; D000076122:Disks Large Homolog 4 Protein; C501449:Dlg4 protein, rat; D018765:Dopamine Uptake Inhibitors; D000072233:Homer Scaffolding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D017470:Receptors, Glutamate; D003042:Cocaine